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Objectives: Recently a biocompatible bone adhesive was introduced in addition to the sternal wires to expedite
sternal union and improve patient recovery. In this study we aim to objectively assess the biomarker of pain in
patient who received the biocompatible bone adhesive.
Methods: A total of 62 patients who underwent sternotomy were prospectively randomised to receive either
conventional wire closure (CWC); 32 patients or adhesive enhanced closure in addition to sternal wire (AEC); 30
patients. Patients were monitored postoperatively at certain time intervals for incisional pain, serum Interleukin-6
(IL-6) level, analgesia used and postoperative complications. All patients were followed up for 4 weeks.
Results: The post-operative pain scores with coughing were significantly higher in the CWC group at 24 hours and
48 hours. The postoperative IL 6 levels were significantly higher in the CWC group in comparison with the AEC
group at 6 hours, 24 hours, and 48 hours. There were no significant differences in term of additional analgesia used.
No adverse events from adhesive bone cement were observed during follow up.
Conclusions: Adhesive-enhanced sternal closure resulted in modest reduction of pain confirmed by reduction of
pain biomarker. Justification of its routine use requires larger multicentre study.
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Since its introduction in 1957 median sternotomy has
been be the most popular incision to access the cardiac
structures for open heart surgery [1]. Despite the recent
advances in minimal access and robotic cardiac surgery,
median sternotomy remains the incision of choice and
will probably continue to be popular in the future [2,3].
The complications from median sternotomy include
acute and chronic pain, instability, non-union, malunion
and infections [4,5]. Each of these complications can
vary in severity and can be potentially fatal especially in
the case of deep sternal wound infection [6]. Closure
techniques with efficient early mechanical stability are
very important for the functional recovery and reducing
the risk of these complications [7]. Recently a novel* Correspondence: hashim.shahrul@yahoo.com.my
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unless otherwise stated.biological bone adhesive (Kryptonite, doctors Research
Group Inc, Southbury, CT) was introduced to facilitate
sternal closure [8,9]. A few studies had demonstrated its
safety and effectiveness in term of pain, respiratory func-
tion and quality of life [8,10,11]. However majority of
these findings especially pain can be subjective especially
when measured using currently available visual pain
score tools. We therefore aim to compare the utilisation
of the biological bone adhesive as an adjunct to the con-
ventional sternal closure versus conventional closure
alone in term of an objective pain assessment utilising a
serum cytokine as a pain biochemical marker in addition
to the standard visual pain score analysis.Methods
Study design and settings
This is a single blinded prospective randomised study
conducted in a single centre between July 2012 and
December 2012. University Malaya Medical Centre is al. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Malaysia serving a population of up to 3 million people.
The cardiothoracic unit performs up to three hundred
fifty adult open heart surgeries per year. The study was
funded by the local university research grant. Ethical ap-
proval was obtained from the University Malaya Medical
Centre Kuala Lumpur Malaysia ethics committee. The
patients were randomly assigned to either closure with
conventional wire closure (CWC) or adhesive enhanced
closure group (AEC). All patients, caregivers and re-
search assistant were blinded to the intervention. The
patients received standard postoperative care and stand-
ard analgesia protocol. All data were collected by a
research assistant and were stored in a secured site at
the hospital.
Study population
Consecutive adult patients over the age of 18 who were
undergoing first time elective or semi elective open heart
surgery through a median sternotomy were invited for
the study. Exclusion criteria were:
– Emergency surgery (defined as surgery within
24 hours of diagnosis)
– At high risk of postoperative bleeding (taking
antiplatelet within 5 days of surgery, redo surgery)
– Previous radiotherapy to chest wall
– Preoperative condition which can potentially cause
prolonged recovery such as significant respiratory
disease, renal failure on dialysis, current used of
steroid or current substances abused
Conduct of study
All patients were randomly assigned to receive either
closure with conventional wire closure (CWC group) or
adhesive enhanced closure (AEC group). A computer-
generated random numbers were used for randomization
of subjects into each group. Whereas the surgeons were
aware of the allocated intervention or control group, pa-
tients, outcome assessors and data analysts were kept
blinded to the allocation. The anaesthesia and surgery
were performed according to routine standard of care. For
sternal closure, all sternums were reapproximatted with 5
figure-of-8 sternal wire size 5. The AEC group received an
additional bone adhesive on top of the standard closure.
The use of bone wax was prohibited. In the AEC group,
the trabeculae of each hemi sternum were cleaned with
the provided brush and irrigated with saline solution. The
‘Kryptonite’ bone adhesive was mixed for 5 minutes and
following which 5 ml of adhesive was applied as a thin
layer to each hemi sternum at the trabeculae interface. Be-
fore the adhesive became complete set which was about
8 minutes the two hemi sternum were approximated. An
additional 15 minutes of operative time were utilised forthe application of the biological bone adhesive. The soft
tissue and skin were closed in a routine manner in both
groups. Post operatively the cares were identical in both
groups. All patients received a standardized postoperative
oral analgesia protocol which comprised of oral Paraceta-
mol (PCM) 1 g QID and capsule Tramadol 50 mg TDS.
Standard preoperative demographic data of the patients
were collected. The primary outcome for this study was
post-operative pain measurement. Biochemical marker of
pain was measured by monitoring the serum Interleukin-6
(IL 6). The serum IL 6 (pg/ml) was measured preopera-
tively and at 6 hours, 24 hours, 48 hours and 72 hours
postoperatively. IL 6 was measured with a commercially
available enzyme linked immunosorbent assay (ELISA).
The Visual Analogue Score (VAS) based on Wong-Baker
faces pain scale which utilizes of face depictions that range
from happy to tearful (0 = none, 10 = worst pain ever)
were collected by a research assistant at 24 hours,
48 hours, 72 hours, and day 7 at rest and at coughing
postoperatively. Also recorded as secondary outcome were
complications following surgery which include death,
chest reopen, perioperative MI, renal failure, pneumonia
and sternal wound infection. The patients were followed
up until 4 weeks following surgery.
Statistical analysis
Based from the previous study the ability to detect the
differences in pain score measurement of 3 (range 0–
5.5) between the two groups were used to calculate our
sample. We estimated that the enrolment of 50 patients
would provide a power of 80% to detect the anticipated
difference in primary outcome at a two-sided alpha level
of 0.05. To allow for drop out, a total of 62 patients were
recruited during the study period.
All analysis was based on intention-to-treat principle.
All data were entered and statistical analysis were per-
formed using SPSS for Windows version 15 (SPSS Inc,
Chicago, IL). Categorical data were expressed as per-
centage and analysed using Chi-Square test. Parametric
data which were normally distributed were reported as
mean +/− standard deviation and analysed with One-
Way-Anova using Bonferonni correction to test for
significance. Non parametric data which had skewed
distribution were analysed using Kruskal-Wallis Test
and reported as median. Values of p less than 0.05 were
considered significant.
Results
Between October 2012 and December 2012, a total of 78
patients were asses for eligibility into the study (Figure 1).
Of the 64 eligible patients 2 refused to participate. The
study population demographic demonstrated more male
patients with majority receiving a coronary bypass graft
surgery (Table 1). The baseline characteristics of the 62
Figure 1 Patients recruitment flow diagram according to
CONSORT guidelines.
Table 1 Baseline characteristics of study population
Variables CWC (n = 32) AEC (n = 30) p Value
Age (mean +/−SD) 60 +/− 35 61.5 +/− 54 0.558
Body mass index (kg/m2) 24.37 +/− 14.78 24.88 +/− 22.96 0.522
Male gender 24 (75.0) 22 (73.3) 0.881
Diabetes 22 (68.7) 19 (63.3) 0.652
Hypertension 24 (75) 22 (68.7) 0.659
IHD 31 (96.8) 26 (86.6) 0.071
Hyperlipidaemia 8 (25) 11(36.6) 0.472
Bronchial Asthma 3 (9.3) 3 (10) 0.140
CABG 30 (93.7) 24 (80.0) 0.195
Valve replacement 1 (3.1) 5 (16.7)
CABG and valve 1 (3.1) 1 (3.3)
All data presented as n (%) unless specified otherwise.
CWC: Conventional wire closure.
AEC: Adhesive enhanced closure.
CABG: Coronary artery bypass graft surgery.
IHD: Ischaemic heart disease.
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coronary artery bypass cases are done using cold blood
cardioplegic arrest and cardiopulmonary bypass tech-
niques. All coronary bypass surgery cases utilised single
internal mammary artery and saphenous veins as con-
duit. All patients were followed up for a period of
1 month. All enrolled patients completed the trial with
no patients lost to follow up.Primary outcome
The pain score were measured in both groups at specific
interval at rest and during coughing. At rest, there were
no significant differences in the postoperative pain score
between the two groups at all the specific interval. Al-
though there were trend of higher pain score in the
CWC group (Table 2). However during coughing the
postoperative pain score were significantly higher in the
CWC group in comparison with the AEC group at
24 hours (8.04 +/− 1.43 vs. 7.00 +/− 2.09, p = of 0.042)
and at 48 hours (7.12 +/− 1.60 vs. 5.27 +/− 1.971,
p = 0.001). At 72 hours and 7 days post-surgery the pain
score were not significantly higher in the CWC group
during coughing.
The levels of IL 6 were similar in both groups preopera-
tively. The postoperative IL 6 levels were significantly
higher in the CWC group in comparison with the AEC
group at 6 hours (15.987 +/− 5.528 vs. 12.809 +/− 5.593,
p = 0.044), 24 hours (15. 795 +/− 5.045 vs. 12.199 +/−
5.890, p = 0.021) and 48 hours (15.770 +/− 5.526 vs.
12.056 +/− 5.046, p = 0.015) (Table 3). At 72 hours the
level was also higher in the CWC group but not statisti-
cally significant.Table 2 Visual analogue pain score at rest and coughing
CWC (n = 32) AEC (n = 30)
Outcome variables Mean +/− SD Mean +/− SD p Value
Incisional pain at rest
Time post operative
24 hours 5.04 +/− 2.735 4.27 +/− 2.201 0.269
48 hours 3.88 +/− 2.42 2.77 +/− 1.945 0.073
72 hours 2.46 +/− 2.319 1.81 +/− 1.877 0.269
Day 7 1.21 +/− 1.668 1.00 +/− 1.865 0.685
Incisional pain with coughing
Time post-operative
24 hours 8.04 +/− 1.43 7.00 +/− 2.09 0.042
48 hours 7.12 +/− 1.608 5.27 +/− 1.971 0.001
72 hours 5.31 +/ - 2.168 4.65 +/− 2.077 0.272
Day 7 3.38 +/− 1.84 2.96 +/− 2.17 0.477
CWC: Conventional wire closure.
AEC: Adhesive enhanced closure.
Table 3 Interleukin 6 level
CWC(n = 32) AEC(n = 30)
Outcome variables Mean +/− SD Mean +/− SD p Value
Pre-op 7.44 +/− 7.86 5.53 +/− 6.01 0.353
Time post-operative
6 hours 15.987 +/− 5.528 12.809 +/− 5.593 0.044
24 hours 15. 795 +/− 5.045 12.199 +/− 5.890 0.021
48 hours 15.770 +/− 5.526 12.056 +/− 5.046 0.015
72 hours 13.752 +/− 6.325 11.438 +/− 4.782 0.150
CWC: Conventional wire closure.
AEC: Adhesive enhanced closure.
Table 5 Additional analgesia used
Variable CWC(n = 32) AEC(n = 30) p Value
Yes 5 (15.6%) 2 (6.7%) 0.246
All data presented as n (%) unless specified otherwise.
CWC: Conventional wire closure.
AEC: Adhesive enhanced closure.
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There were 2 deaths in the CWC group but was not sta-
tistically significant between the two groups. There was
one chest reopen for bleeding in the AEC group. During
the chest reopening there was no difficulty in separating
the sternum as it was done 3 hours postoperatively
before the adhesive set fully. Another application of
adhesive was used for this patient to prevent exclusion
or cross over in the study. There was more superficial
sternal wound infection in the AEC group but not statis-
tically significant (Table 4). However there was no inci-
dence of deep sternal wound infection in both groups.
Other outcome
Additional usages of analgesia were also measured dur-
ing the post-operative period. Although not statistically
significant, the patients in the CWC group required
more additional analgesia (Table 5).
Discussion
Recovery from a median sternotomy remains one of the
major factors in the outcome following an open heart
surgery [12]. Normally it takes up to six week for full
bony union between the two hemi sternum during
which time the patient can suffer from varying amount
of pain and functional disability [12]. The standard clos-
ure of sternotomy involves reapproximating the twoTable 4 Post-operative complications
Variables CWC(n = 32) AEC(n = 30) p Value
Mortality 2 (6.25%) 0 (0%) 0.164
Chest re-open 0 (0%) 1 (3.33%) 0.313
Per-ioperative MI 1 (3.125%) 1 (3.33%) 1.000
Renal failure 2 (6.25%) 0 (0%) 0.150
Pneumonia 2 (6.25%) 0 (0%) 0.150
SSWI 1 (3.125%) 4 (13.3%) 0.161
DSWI 0 (0%) 0 (0%) 0.419
CWC: Conventional wire closure.
AEC: Adhesive enhanced closure.
SSWI: Superficial sternal wound infection.
DSWI: Deep sternal wound infection.hemi sternum with multiple stainless steel wires. The
configurations of the wires can be a figure of eight or a
single loop. Other techniques have been introduced to
improved early sternal stability and prevent complica-
tions such as sternal non-union, fracture of osteoporotic
bone during closure or mediastinitis. The most popular
technique is the Robicsek closure or its modification
technique. In this technique essentially the 2 loops of
sternal wire along the length of the sternum placed para-
sternally and multiple individual transverse sternal wires
are loop around the longitudinal wire reapproximating
the sternum [4,13]. Other techniques include using
double wires loop, steel rod, plates or special clips
[14,15]. However majority of these techniques requires
additional introduction of wires or rod which may cause
increase risk of bleeding.
In an attempt to improve and expedite the rigid stabil-
ity between the two hemi sternum, addition of an adhe-
sive type material like bone cement would be a next
logical step. In orthopaedic surgery bone cement is rou-
tinely used for joint replacement surgery. Unfortunately
the type of cement used has exothermic property where
the temperature can reach up to 40 degree Celsius when
it cures which make it unsuitable in open heart surgery
due to the potential contact of the cement with the myo-
cardial surface [16]. Furthermore this cement is normally
non porous which does not allow natural osteointergra-
tion for sternal union [17]. A new biocompatible bone
cement or adhesive used in our study composed of
naturally occurring fatty acid and calcium carbonate
derived from castor oil. The material does not exert sig-
nificant heat during the setting period and takes
approximately 24 hour to be fully set. When fully set there
are porous networks in the adhesive which allowed host
osteoblast to synthesise new bone within the networks [18].
A cadaveric study of human sternum demonstrated
that the biological bone adhesive provide significant
strength to the union between two hemi sternum in
combination with sternal wire at 24 hours. In this study
wire cerclage alone cause 2 mm lateral displacement of
the two hemisternum with load as low as 400 Newton.
The addition of biological bone adhesive required a
load of 600 Newton or greater to cause lateral displace-
ment [8]. The same study also demonstrated the safety
of the material in human subject with SPECT evidence
of osteosynthesis between the two hemisternum at
12 months [8].
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sive resulted in a significant reduction of pain at various
intervals as early as 72 hours following surgery at rest
and during physiological stress such as coughing [10].
As early sternal stability and pain can contribute to the
respiratory function, the authors have also demonstrated
significant improvement in inspiratory capacity at
72 hours following surgery in the adhesive enhanced
closure group. The rapid return to baseline health re-
lated quality of life was demonstrated as early as 3 weeks
in the adhesive enhanced closure. The risk for sternal
complication is increasing in the current cardiac surgery
population which include older age, obesity, osteopor-
osis, diabetes, COPD and utilisation of bilateral internal
mammary artery [19,20]. This adjunct technique of
achieving early bony union most likely will benefits these
high risk groups of patients. Early bony union will un-
doubtedly reduce the stress on the bone from the sternal
wire hence reduce risk of complication of sternal non-
union. A recent study has demonstrated the benefits of
the adhesive enhanced sternal closure in this group of
patients. In the study, high risk group such as the elderly
experienced no severe pain, improved respiration and
achieved early good quality of life [11].
In our study we have focused mainly on the pain expe-
rienced by the patients. To be more objective we have
utilised the visual analogue score and Interleukin 6 (IL
6) as pain biomarker to quantify pain. In our study, the
adhesive enhanced group demonstrated significant
reduction of incisional pain score during coughing post-
operative at 24 and 48 hours. These findings can be
explained as the adhesive takes approximately 24 hours
to be fully set. In our study the pain score were not sig-
nificantly higher at rest. It has been shown that after a
standard method of closure with wires alone, micro
movement occurred between the two hemisternum dur-
ing physiological distraction such as coughing [21]. The
micro movement can cause discomfort for the patients
and potentially delayed the healing and increase the risk
of sternal infection. The lack of micro movement at rest
explained similar pain score experienced at rest by the
two groups. At 72 hours the pain score was less in the
adhesive group but was not statistically significant. In
Fedak et al. study the pain score at 72 hours was signifi-
cantly reduced in the adhesive enhanced group. This
could be explained by our dual analgesia protocol of
non-opioid and opioid in both groups.
In our study the absolute value of pain reduction al-
though significant is small ranging from 0.6 to 1.91.
These values are lower than the predicted value of 3
during the planning of the study and also lower than a
previous study [10]. As pain is a subjective measure with
significant interpersonal variability and depends on the
type and reliability of the pain scale used, a moreobjective assessment of pain with a biochemical marker
was done to substantiate the advantage of adhesive en-
hanced closure. IL 6 a biomarker used in this study is an
inflammatory cytokine that has an important role in the
physiology of nociception and the pathophysiology of
pain. Its receptor gp80, and its transmembranous signal
transducer gp 130 are up-regulated in periphery nerves,
dorsal root ganglia and spinal cord during experimental
pain [22]. In human IL 6 is among the most sensitive
indicator of the degree of surgical stress [23]. Previous
studies have shown a reduction in IL 6 level post
thoracotomies when there were reduction in pain due
to additional pain controlled methods such as
additional NSAID and TENS [24,25]. We have not in-
cluded other set of biomarkers such as CRP TNF or
other Interleukin due to the previous studies explained
earlier which suggest IL 6 is the most accurate bio-
marker for pain. Furthermore the main aim of the
study is pain assessment and not surgical stress. Our
data demonstrated in comparison with conventional
sternal closure, the adhesive enhanced closure was as-
sociated with significant lower level of IL 6 at 6, 24
and 48 hours post-surgery. In our study the invasive-
ness of surgery was similar in both groups. Thus as an
indirect objective marker of pain, lower level of IL 6
released in the AEC group confirmed the advantage of
the biological bone adhesive as an adjunct to conven-
tional sternal closure. The porosity of the bone adhe-
sive which allows osteointergration implied that the
biological bone adhesive does not reduced inflamma-
tory response which can contribute to lower IL 6 level.
Indirectly, the lower level of IL 6 in the AEC group
may purely due to reduced pain response.
In our study the utilisation of additional analgesia were
lower in the treatment group but was not statistically
significant which did not replicate the findings from
Fedak et al. study where the level of overall opioid usage
were statistically less in the adhesive enhanced closure
group. The reason for this finding may be due to the fact
that our standard post-operative analgesia protocol
which include oral opioid. All the additional analgesia
used in our study was opioid base infusion.
In the study there were more superficial sternal wound
infections in the treatment group but not statistically
significant. Although occasionally superficial sternal
wound infection can progress to deep sternal wound in-
fection, none of the patients developed deep sternal
wound infection. All the infections were successfully
treated with intravenous antibiotics. We therefore be-
lieve that the utilisation of the bone adhesive did not
contribute to the superficial wound infection. There
were no other significant complications from the utilisa-
tion of the bone adhesive in our study. In the literature
there has been no adverse reaction reported with the
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verse reaction or limitation include allergic reaction, ex-
cessive spillage into mediastinum compressing grafts
after approximation of sternum, possible arrhythmias
from the slight heat generated from the adhesive whilst
it set. Other limitation include the necessity of an oscil-
lating saw should the case require a chest reopen after
24 hour when the adhesive is fully set.
Study limitation
In our study, several limitations were identified. The
small number in size could have contributed to the non-
significant results at 72 hour following surgery. Inclusion
of multiple types of open heart surgery procedures
which involves sternotomy might have influenced some
of our findings. Our follow up is only for one month
with no measurement of quality of life which may have
added further strength to the study. Our standard dual
analgesia protocol of non-opioid and opioid could have
contributed to some of non-significant results when
compare to other studies. Utilisation of only non-opioid
analgesia to see reduction of opioid usage would be use-
ful in future studies.
Conclusion
The large reduction in pain score from other studies
has not been replicated in our study. The addition of
biological bone adhesive to the standard method of
sternal closure resulted in marginal significant reduc-
tion of pain although confirmed by the reduction of
pain biomarker released. Due to the marginal improve-
ment of pain together with similar requirement of anal-
gesia its clinical significant maybe doubtful base on our
current study. As a new product the safety of its use
was shown in several studies including ours. Limita-
tions for its use would be the additional cost it incurs
and the modest improvement in pain score base from
our study. Further larger multi-centre trial with longer
follow-up together with cost benefits analysis to con-
firm its clinical benefits further is needed before this
technique can widely adopted.
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